While the most common somatic mutations in melanoma occur in the RAF-MEK-ERK pathway (BRAF, NRAS, NF1, MAP2K1, KIT), EZH2 mutations have been identified in up to 6–7% of melanoma cases26–28. This evidence concerns the gene EZH2 and melanoma.